Literature DB >> 9183259

Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia.

R C Henderson1.   

Abstract

Forty-three patients with spastic quadriplegia (mean age 7.9 years, range 3.3 to 17.2 years) underwent bone mineral density (BMD) measurement of the lumbar spine and were evaluated between 2.6 and 5.5 years (mean 3.8) later to determine whether this measurement had predicted risk of fracture over the subsequent period of observation. Other potential risk factors that were evaluated include body weight z score, serum vitamin D levels, previous fracture, and hip spica casting. The baseline measurements showed that BMD falls further below normal with increasing age and was more than one standard deviation below age-matched normal mean in 38 of the 43 patients. Fracture rate did not differ between those with low and those with very low spinal BMD. Similarly, serum vitamin D levels and body weight z scores were not predictive of fracture. However, fracture rate was over fourfold greater following spica casting and more than threefold greater following an initial fracture. Fracture rates in the study group were similar to those reported for age- and sex-matched normal children, though generally the location of the fractures and mechanisms of injury differed.

Entities:  

Mesh:

Year:  1997        PMID: 9183259     DOI: 10.1111/j.1469-8749.1997.tb07415.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  27 in total

1.  Results and complications of percutaneous pelvic osteotomy and intertrochanteric varus shortening osteotomy in 54 consecutively operated GMFCS level IV and V cerebral palsy patients.

Authors:  Federico Canavese; Lorenza Marengo; Geraldo de Coulon
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-01-12

Review 2.  Growth and nutrition disorders in children with cerebral palsy.

Authors:  Michelle N Kuperminc; Richard D Stevenson
Journal:  Dev Disabil Res Rev       Date:  2008

Review 3.  Pain in cognitively impaired children: a focus for general pediatricians.

Authors:  M Massaro; S Pastore; A Ventura; E Barbi
Journal:  Eur J Pediatr       Date:  2012-03-20       Impact factor: 3.183

4.  Efficacy of home-based virtual cycling training on bone mineral density in ambulatory children with cerebral palsy.

Authors:  C-L Chen; C-Y Chen; M-Y Liaw; C-Y Chung; C-J Wang; W-H Hong
Journal:  Osteoporos Int       Date:  2012-09-28       Impact factor: 4.507

Review 5.  The Effects of Resistance Training on Health of Children and Adolescents With Disabilities.

Authors:  Kirsten Legerlotz
Journal:  Am J Lifestyle Med       Date:  2018-02-28

6.  Bone densitometry in pediatric patients treated with pamidronate.

Authors:  Leslie E Grissom; Heidi H Kecskemethy; Steven J Bachrach; Charles McKay; H Theodore Harcke
Journal:  Pediatr Radiol       Date:  2005-01-18

7.  Adaptation of the lateral distal femur DXA scan technique to adults with disabilities.

Authors:  Richard C Henderson; Brent A Henderson; Heidi H Kecskemethy; Sebastian T Hidalgo; Beth Ann Nikolova; Kevin Sheridan; H Theodore Harcke; Deborah E Thorpe
Journal:  J Clin Densitom       Date:  2014-06-03       Impact factor: 2.617

8.  A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy.

Authors:  J M Caulton; K A Ward; C W Alsop; G Dunn; J E Adams; M Z Mughal
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

9.  Peripheral quantitative computed tomography (pQCT) reveals low bone mineral density in adolescents with motor difficulties.

Authors:  B Hands; P Chivers; F McIntyre; F C Bervenotti; T Blee; B Beeson; F Bettenay; A Siafarikas
Journal:  Osteoporos Int       Date:  2015-03-10       Impact factor: 4.507

10.  Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome.

Authors:  Kathleen J Motil; Kenneth J Ellis; Judy O Barrish; Erwin Caeg; Daniel G Glaze
Journal:  Pediatr Res       Date:  2008-10       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.